Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEyal Ben David - CEOJiahong Li - Co-CEO and CFOLior Dayan - ChairmanConference Call ParticipantsJin Xin Ding - AnalystJingheng He - AnalystNate Zhou - Equity Research AnalystNone - AnalystJingheng HeLadies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joini ...

Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Company ParticipantsEyal Ben David - CEOJiahong Li - Co-CEO and CFOLior Dayan - ChairmanConference Call ParticipantsJin Xin Ding - AnalystJingheng He - AnalystNate Zhou - Equity Research AnalystNone - AnalystJingheng HeLadies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joini ...

Sisram Medical (SEHK:01696) H2 2025 Earnings call March 24, 2026 08:00 AM ET Speaker3Ladies and gentlemen, thank you for standing by, and welcome to Sisram Medical's 2025 annual results conference call. I am Jingheng He from CITIC Securities, and joining me today is our Chief Analyst, Yifan Du. Joining us online on today's call is Sisram Medical's senior management team. They are Mr. Lior Moshe Dayan, Chairman. Mr. Eyal Ben David, Chief Executive Officer. Mr. Jiahong Li, Co-Chief Executive Officer and Chief ...